Author(s): Gabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et. al. Abstract: P 605 Session topic: 8. Chronic myeloid leukemia – Clinical Background: Nilotinib has shown better efficacy compared to imatinib, but it has been associated to a higher incidence of arterial thrombotic events (ATEs). Little is known on the impact of ATEs on...
Pro zobrazení tohoto obsahu je třeba být přihlášen.